406 POSTER Safety and efficacy of sunitinib malate (SU11248) as second-line therapy in metastatic breast cancer (MBC) patients: preliminary results from a phase II study
2005 ◽
Vol 3
(2)
◽
pp. 113-114
◽
Keyword(s):
Phase Ii
◽
2015 ◽
Vol 51
◽
pp. S291-S292
◽